Connect your AI

Cogent Biosciences, Inc. COGT Earnings yield

Earnings yield at other companies

PfizerPFE

6.8%—

AmgenAMGN

4.1%+0.6pp

IncyteINCY

7.6%+7.5pp

Tango TherapeuticsTNGX

-3.6%-1.8pp

CG OncologyCGON

-3.3%-1.0pp

Scholar RockSRRK

-7.2%-1.0pp

Other financials

Income statement

Operating income-$103.6M-38.3%

Net income-$97.4M-35.2%

EPS (diluted)-$0.53-1.9%

Balance sheet

Cash & equivalents$241.2M+91.4%

Total debt$15.5M-9.4%

Total equity$607.7M+177%

Total assets$903.0M+218%

Cash flow

Operating cash flow-$86.9M-30.6%

CapEx$449.0K-17.9%

Free cash flow-$87.3M-30.2%

Valuation

Market cap$5.9B+816%

Enterprise value$5.68B+951%

P/S749.8×—

Profitability

Operating margin-1,044.3%—

Net margin-950.4%—

FCF margin-184.7%—

Returns & leverage

Return on equity-85.7%+1.7pp

Debt / equity0×-0.1×

Current ratio15.1×+10.0×

Where this comes from

Calculated from Cogent Biosciences, Inc.’s reported figures.

net income/market cap=-5.7%

Based on trailing twelve months.

The official record: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cogent Biosciences, Inc.'s earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Cogent Biosciences, Inc.'s earnings yield?: Cogent Biosciences, Inc. (COGT) reported earnings yield of -5.7% in Q1 2026.
How has Cogent Biosciences, Inc.'s earnings yield changed year-over-year?: Cogent Biosciences, Inc.'s earnings yield increased by 85.6% year-over-year, from -39.5% to -5.7%.
What is the long-term trend for Cogent Biosciences, Inc.'s earnings yield?: Over 5 years (2020 to 2025), Cogent Biosciences, Inc.'s earnings yield has grown at a -18.4% compound annual growth rate (CAGR), from -16.7% to -6%.
What does earnings yield mean?: Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.